Stephen W. Potter
Corporate Officer/Principal bei APPLIED GENETIC TECHNOLOGIES CORPORATION
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| David Fellows | M | 67 | 2 Jahre | |
| Chris Hollowood | M | 50 | 2 Jahre | |
| Matthew Feinsod | M | - | 10 Jahre | |
| Gerald Reynolds | M | - | 4 Jahre | |
| Ashwin Datt | M | - | 2 Jahre | |
| Janet Rae | F | - | 3 Jahre | |
| Abraham Scaria | M | - | 3 Jahre | |
| Nadia Waheed | M | 47 | 2 Jahre | |
| Hope D'Oyley-Gay | F | - | 3 Jahre | |
| David Jacobs | M | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Susan B. Washer | F | 63 | 21 Jahre | |
| Robert S. Vaters | M | 63 |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | - |
| Keith David Hartt | M | 63 |
University of Massachusetts
| 14 Jahre |
| David Mazzo | M | 67 |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | - |
| William A. Sullivan | M | 52 | 4 Jahre | |
| Gloria Matthews | M | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 Jahre |
| Cuneyt Oge | M | - |
University of Massachusetts
| 6 Jahre |
| David Altarac | M | 63 |
NeoStem, Inc. /Old/
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | 2 Jahre |
| Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 Jahre |
| Akbar Moawalla | M | - |
University of Massachusetts
| 6 Jahre |
| Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Hans Klingemann | M | 74 | 4 Jahre | |
| Donald G. Coffey | M | 69 |
University of Massachusetts
| 6 Jahre |
| Steven H. Gardner | M | - |
University of Massachusetts
| 6 Jahre |
| James Rosen | M | 55 | 12 Jahre | |
| Rabia Ozden | M | 56 | 3 Jahre | |
| Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 Jahre |
| Scott Koenig | M | 71 | 20 Jahre | |
| Gregory H. Barnhill | M | 71 | 6 Jahre | |
| David Guyer | M | 64 | 3 Jahre | |
| Richard C. D'Addario | M | - |
University of Massachusetts
| 6 Jahre |
| Bruce Peacock | M | 72 | 1 Jahre | |
| Lawrence E. Bullock | M | 67 | 3 Jahre | |
| Edward Hurwitz | M | 60 | 10 Jahre | |
| Steven Klosk | M | 67 |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | - |
| Arnold Lewis Oronsky | M | 83 | 14 Jahre | |
| Robin Smith | M | 59 |
NeoStem, Inc. /Old/
| 9 Jahre |
| Frank D. Czworka | M | 55 | 5 Jahre | |
| Peter Traber | M | 69 |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | - |
| Ivana Magovcevic-Liebisch | M | 55 | 8 Jahre | |
| Henry E. Blair | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 Jahre |
| Richard F. Syron | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Anne VanLent | F | 76 | 6 Jahre | |
| Daniel Robert Fritz | M | 69 |
University of Massachusetts
| 4 Jahre |
| Paul J. Smith | M | - |
University of Massachusetts
| 4 Jahre |
| Helinka Mills | F | - |
University of Massachusetts
| 4 Jahre |
| Sean Carrara Tanuwidjaja | M | 70 |
University of Massachusetts
| 4 Jahre |
| Evelyn Cole Smith | F | - |
University of Massachusetts
| 4 Jahre |
| David Wandrei | M | - |
University of Massachusetts
| 4 Jahre |
| Richard G. LaVoice | M | - |
University of Massachusetts
| 4 Jahre |
| Eugenia Ulasewicz | M | 70 |
University of Massachusetts
| 4 Jahre |
| Julie Ann Goodwin | F | 63 |
University of Massachusetts
| 4 Jahre |
| Antonia M. Donohue | F | 65 |
University of Massachusetts
| 4 Jahre |
| Jeffrey Nadison | M | - |
University of Massachusetts
| 4 Jahre |
| Andrew E. Viens | M | 69 |
University of Massachusetts
| 4 Jahre |
| Mark Shawn Frank | M | 62 |
University of Massachusetts
| 4 Jahre |
| Miriam C. Weiler | F | - |
University of Massachusetts
| 4 Jahre |
| Carol Harlow | F | - |
University of Massachusetts
| 4 Jahre |
| Richard Billings | M | - |
University of Massachusetts
| 4 Jahre |
| Jerrold L. Sklar | M | - |
University of Massachusetts
| 4 Jahre |
| Glenn Fox | M | - |
University of Massachusetts
| 4 Jahre |
| Michael Stewart Wilkins | M | - |
University of Massachusetts
| 4 Jahre |
| Steve Graziano | M | - |
University of Massachusetts
| 4 Jahre |
| Joe Wiltshire | M | - |
University of Massachusetts
| 4 Jahre |
| Peter deSilva | M | 62 |
University of Massachusetts
| 5 Jahre |
| Edward Shirley | M | 66 |
University of Massachusetts
| 4 Jahre |
| Richard D. Ames | M | 76 |
University of Massachusetts
| 4 Jahre |
| Craig C. Reed | M | 71 |
University of Massachusetts
| 4 Jahre |
| Jorge Rodriguez-Lugo | M | - |
University of Massachusetts
| 4 Jahre |
| Steven Graves | M | - |
University of Massachusetts
| 4 Jahre |
| Peter Kiener | M | 72 |
University of Massachusetts
| 4 Jahre |
| Bruce Berkowitz | M | 65 |
University of Massachusetts
| 4 Jahre |
| Kathleen Cahill Gaffney | F | 63 |
University of Massachusetts
| 4 Jahre |
| Richard L. Pyle | M | 79 |
University of Massachusetts
| 3 Jahre |
| Scott Hyney | M | - |
University of Massachusetts
| 4 Jahre |
| Barbara Jean Cummings | F | - |
University of Massachusetts
| 3 Jahre |
| Fred E. Berkowitz | M | - |
University of Massachusetts
| 5 Jahre |
| Dan Joyce | M | 68 |
University of Massachusetts
| 3 Jahre |
| Michael Joseph Carne | M | - |
University of Massachusetts
| 5 Jahre |
| David V. Devault | M | 69 |
University of Massachusetts
| 4 Jahre |
| Gene DiPoto | M | - |
University of Massachusetts
| 4 Jahre |
| Steven Willis | M | - |
University of Massachusetts
| 5 Jahre |
| Balaji Krishnamurthy | M | 70 |
University of Massachusetts
| 3 Jahre |
| Henry E. Schea | M | 71 |
University of Massachusetts
| 4 Jahre |
| Doug Suliman | M | 68 |
University of Massachusetts
| 4 Jahre |
| Stuart Zerneri | M | - |
University of Massachusetts
| 4 Jahre |
| Scott Sandler | M | - |
University of Massachusetts
| 5 Jahre |
| Douglas D. Nicoll | M | - |
University of Massachusetts
| 4 Jahre |
| Michael F. Shepard | M | 78 |
University of Massachusetts
| 4 Jahre |
| Robert Edward McKenna | M | - |
University of Massachusetts
| 4 Jahre |
| Ronald B. Gorda | M | - |
University of Massachusetts
| 4 Jahre |
| Robert Dickey | M | 68 |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | 2 Jahre |
| John N. McMullen | M | 65 |
University of Massachusetts
| 4 Jahre |
| Edward A. Giedgowd | M | - |
University of Massachusetts
| 4 Jahre |
| Robert A. Massey | M | 73 |
University of Massachusetts
| 4 Jahre |
| Stanley L. Korzeb | M | 69 |
University of Massachusetts
| 4 Jahre |
| Alfred Grasso | M | 65 |
University of Massachusetts
| 4 Jahre |
| Mark Tutun | M | - |
University of Massachusetts
| 4 Jahre |
| Alan Nathan Hoffman | M | - |
University of Massachusetts
| 4 Jahre |
| David R. Knower | M | 63 |
University of Massachusetts
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Stephen W. Potter
- Persönliches Netzwerk
